Keyphrases
Hypertrophic Cardiomyopathy
100%
Glycogen Storage Disease
100%
LAMP2
100%
Genetic Analysis
42%
Left Ventricular Hypertrophy
42%
Electrophysiological Characteristics
42%
PRKAG2
42%
Ventricular Pre-excitation
42%
PRKAG2 mutation
42%
Left Ventricular Wall Thickness
28%
Hypertrophy
28%
β-Galactosidase (β-Gal)
28%
Glycogen
14%
Clinical Features
14%
Proband
14%
Gene Regulating
14%
AMP-activated Protein Kinase
14%
Male Sex
14%
Early Onset
14%
Serum Proteins
14%
Multisystem
14%
Gene Defects
14%
Protein mutations
14%
Glycogen Metabolism
14%
Sarcomere Protein Gene
14%
Fabry Disease
14%
Gene Disorders
14%
Protein Kinase 2
14%
Primary Cardiomyopathy
14%
Pompe Disease
14%
Danon Disease
14%
Glycogen Storage Cardiomyopathy
14%
Sarcomere Proteins
14%
4-glucosidase
14%
Medicine and Dentistry
Hypertrophic Cardiomyopathy
100%
Glycogen Storage Disease
100%
Lysosome Associated Membrane Protein 2
100%
Genetic Analysis
42%
Ventricular Hypertrophy
28%
Left Ventricular Hypertrophy
28%
Myocardial Disease
28%
Sarcomere
28%
Galactosidase
28%
Clinical Feature
14%
Electrocardiogram
14%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
14%
Fabry Disease
14%
Serum Total Protein
14%
Glucosidase
14%
Glycogen Metabolism
14%
Glycogen Storage Disease Type II
14%
Danon Disease
14%
Diseases
14%
Biochemistry, Genetics and Molecular Biology
Membrane Protein
100%
Lysosome
100%
PRKAG2
85%
Genetics
42%
Galactosidase
28%
Proband
14%
Electrocardiogram
14%
AMP-activated Protein Kinase
14%
Serum Total Protein
14%
Glucosidase
14%
Fabry Disease
14%
Glycogen Metabolism
14%